Enhancement of T-helper type I immune responses against hepatitis B surface antigen by LPS derivatives adjuvanted liposomes delivery system

References

• CR Alving. 1987. Liposomes as carrier for vaccines. Liposomes from biophysics to therapeutics, MJ Ostro. New York: Marcel Dekker Inc. 195–218.
   Google Scholar
• CR Alving. 1991. Liposomes as carrier of antigens and adjuvants. J Immunol Methods 140:1–13.
   PubMed Web of Science ®Google Scholar
• BP Babbitt, PM Allen, G Matsueda, E Haber, and ER Unanue. Binding of immunogenic peptides to la histocompatibility molecules. Nature 317:359–361. 1985
   PubMed Web of Science ®Google Scholar
• BP Babbitt, PM Allen, G Matsueda, E Haber, ER Unanue, and PM Allen. Antigen competition at the label of peptide-la binding. Proc Natl Acad Sci 83:4509–4513. 1986
   PubMed Web of Science ®Google Scholar
• T Boon, PG Coulie, and B Vanden Eynde. 1997. Tumors antigens recognized by T cells. Immunology Today 18:267–278.
   PubMedGoogle Scholar
• FV Chisari, and C Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29–60.
   PubMed Web of Science ®Google Scholar
• ME Christine, L Deborah, D Sonowski, S Wishart, SK Glen, and J Samuel. 1998. Use of a liposome antigen delivery system to alter immunoresponses in vivo. J Pharma Sci 87:1428–1432.
   PubMed Web of Science ®Google Scholar
• JM Crawford. 1994. The liver and the billiary tract: The liver. In: RS Cotran, V Kumar, and SL Robbins. Robbins pathologic basis of diseases, 5th ed. Bangalore, India: Prism Books (Pvt) Ltd. 844–846.
   Google Scholar
• H Davis. 1996. DNA based vaccination against hepatitis B virus. Adv Drug Del Rev 21:33–47.
   Web of Science ®Google Scholar
• J Dijkstra, R Bron, J Wilschut, DA Haan, and LJ Ryan. 1996. Activation of murine lymphocytes by lipopolysaccharide incorporated in fusogenic, reconstituted influenza virus envelopes (virosomes). J Immunology 157:1023–1036.
   Google Scholar
• J Dijkstra, JW Mellors, and JL Ryan. 1987. Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J Immunol 138:2663–2670.
   PubMed Web of Science ®Google Scholar
• J Dijkstra, JL Ryan, and F Szoka. A procedure of efficient incorporation of wild -type lipopolysacchride into liposomes for use in immunological studies. 144:197–205. 1988
   Google Scholar
• M Fisseha, P Chen, B Brandt, T Kijek, E Moran, and W Zollinger. 2005. Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect Immun 73 (7):4070–4080.
   PubMed Web of Science ®Google Scholar
• DW Fry, JC White, and ID Goldman. 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem 90:809–815.
   PubMed Web of Science ®Google Scholar
• M Geissler, K Tokushige, and J Wands. 1995. Polynucleotide based immunization: Study of the cellular and humoral immune response to hepatitis B virus (Abstr). Hepatology 22:324A.
   Google Scholar
• KJ Hwang. 1987. Liposome pharmacokinetics. In: M Outro. Liposome. New York: Marcel Dekker Inc. 109–156.
   Google Scholar
• A Julia, JI Metcalf, WM Gallin, and RK Nausecf. 1986. Lab manual of neutrophil function. New York: Paven Press. 113–115.
   Google Scholar
• M Kundi. 2007. New hepatitis B vaccine formulated with an improved adjuvant system. Expert Rev Vaccines 6 (2):133–140.
   PubMed Web of Science ®Google Scholar
• K Laemmli. 1970. Cleavage of structural protein during the assembly of head of bacteriophage T4. Nature 227:680.
   PubMed Web of Science ®Google Scholar
• C Leclerc, and J Roneo. 1998. New approaches in vaccine development. Immunol Today 19:302.
   Google Scholar
• I Lowy, J Theze, and L Chedid. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response. J Immunol 124:100–104. 1980
   PubMed Web of Science ®Google Scholar
• DC Maerrison. 1985. Nonspecific interaction of bacterial lipopolysacchride with membrane and membrane counterparts. In: LJ Berry. Cellular biology of endotoxin. Hand book of endotoxin. Amsterdam: Elsevier. 25.
   Google Scholar
• A Marchant, J Duchow, JP Delville, and M Goldman. 1992. Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood. Eur J Immunol 22:1663–1665.
   PubMed Web of Science ®Google Scholar
• K Matsuura, T Ishida, M Setoguchi, Y Higuchi, S Akizuki, and S Yamamoto. 1994. Up regulation of CD14 expression in kupffer cells by lipopolysaccharide. J Exp Med 179:1671–1676.
   PubMed Web of Science ®Google Scholar
• P Moingeon, J Haensler, and A Lindberg. 2001. Towards the rational design of Th1 adjuvants. Vaccine 19:4363–4372.
   PubMed Web of Science ®Google Scholar
• DT O'Hagan, ML Mackichan, and M Singh. 2001. Recent developments in adjuvants for vaccines against infectious dieases. Biomol Eng 18:69–85.
   PubMedGoogle Scholar
• A Otsuka, T Hamafusa, N Kono, and S Tarui. 1991. Lipopolysacchride augments HLA molecules expression but inhibits interferon gamma induced HLA-DR molecule expression on cultured human endothelial cells. Immunology 73:428–452.
   PubMed Web of Science ®Google Scholar
• N Puri, EH Weyand, SM Abdet-Rohman, and PJ Sinko. 2000. An investigation of intradermal route as an effective means of immunization for micro particulate vaccine delivery systems. Vaccine 18:2600–2612.
   PubMed Web of Science ®Google Scholar
• JH Sanior. 1987. Fate and behavior of liposome in vivo: A review of controlling factors. Crit Rev Ther Drug Carrier Syn 3 (2):123–193.
   PubMed Web of Science ®Google Scholar
• S Saraf, D Mishra, A Asthana, R Jain, S Singh, and NK Jain. 2006. Lipid microparticles for mucosal immunization against hepatitis B. Vaccine 24 (1):45–56.
   PubMed Web of Science ®Google Scholar
• L Shi, JC Michael, TC Rey, AW Roger, S Gautam, and BV David. 2002. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci 91:1019–1035.
   PubMed Web of Science ®Google Scholar
• M Singh, and DT O’ Hagan. 1999. Advances in vaccine adjuvants. Nat Biotechnol 17:1075–1081.
   PubMed Web of Science ®Google Scholar
• S Somavarapu, VW Bramwell, and HO Alpar. 2003. Oral plasmid DNA delivery systems for genetic immunization. J Drug Target 21 (21–22):2720–2729.
   Google Scholar
• K Sugimura, M Uemiya, I Saiki, I Azuma, and I Yamamura. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity. Cell Immunol 43:137–149. 1979
   PubMed Web of Science ®Google Scholar
• O Takeuchi, K Hoshino, and T Kawai. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443–451.
   PubMed Web of Science ®Google Scholar
• E Urban, A Bota, B Kocsis, and K Lohner. Distortion of the lamellar arrangement of phospholipids by deep rough mutant lipopolysacchride from Salmonella minnesota. J thermal analysis and calorimetry 82:463–469. 2005
   Web of Science ®Google Scholar
• N Van Rooijen, and D Su. 1989. Immunoadjuvant action of liposomes mechanisms. In: G Gregoriadis, and AG Allision. Immunological adjuvants and vaccines. New York: Plenum Press. 95–106.
   Google Scholar
• P Vander Ley, L Steeghs, HJ Hamstra, J Hove, B Zomer, and L Van Alphen. 2001. Modification of lipid A biosynthesis in Nesseria meningitidis LpxL1 mutants: Influence of lipopolysacchride structure, toxicity and adjuvant activity. Infect Immun 69:5981–5990.
   PubMed Web of Science ®Google Scholar
• N Venkatesan, and SP Vyas. 2000. Polysaccharide coated liposomes for oral immunization. Development and characterization. Int J Pharma 203:169–177.
   PubMed Web of Science ®Google Scholar
• SP Vyas, YK Katare, V Mishra, and V Sihorkar. 2002. Ligand directed macrophage targeting of amphotericin B laoded liposomes. Int J Pharm 210:1–14.
   Google Scholar
• SD Wright, RA Ramos, and JC Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
   PubMed Web of Science ®Google Scholar